| VAV3-D2 Fusion Protein (SH3)
| VAV3-D2 Fusion Protein (SH3)
| |
| VCAM-1 PRIMER PAIR | VCAM-1 PRIMER PAIR | |
| VAV2-D1 Fusion Protein (SH3)
| VAV2-D1 Fusion Protein (SH3)
| |
| VAV2-D2 Fusion Protein (SH3)
| VAV2-D2 Fusion Protein (SH3)
| |
| VAV1-D2 Fusion Protein (SH3)
| VAV1-D2 Fusion Protein (SH3)
| |
| VAV3- D1 Fusion Protein (SH3)
| VAV3- D1 Fusion Protein (SH3)
| |
| VCAM-1 (Soluble) EIA(2 X 96)
| VCAM-1 (Soluble) EIA(2 X 96)
| |
| VCAM-1 (Soluble) EIA
| VCAM-1 (Soluble) EIA
| |
| VCAM-1(Vascuolar cell adhesion molecule 1)CD106 | VCAM-1(Vascuolar cell adhesion molecule 1)CD106 | |
| Vat Yellow 10 | 4',4'''-アゾビス[N-[5-(ベンゾイルアミノ)-9,10-ジヒドロ-9,10-ジオキソアントラセン-1-イル]-1,1'-ビフェニル-4-カルボアミド] | 2379-76-2 |
| Vat Yellow 33 | 4',4'''-アゾビス[N-(9,10-ジヒドロ-9,10-ジオキソアントラセン-1-イル)-1,1'-ビフェニル-4-カルボアミド] | 12227-50-8 |
| Vat Yellow Brown G | Vat Yellow Brown G | |
| Vat Yellow 21 | Vat Yellow 21 | 1328-40-1 |
| Vat Yellow 31 | 2,5-ジクロロ-N-(7-オキソ-7H-ベンゾ[e]ペリミジン-8-イル)ベンズアミド | 6871-93-8 |
| Vat Yellow 11 | Vat Yellow 11 | |
| Vat Yellow 3 | Vat Yellow 3 | |
| VATYELLOW G | VATYELLOW G | |
| Vat yellow 49 | C.I.バットイエロー49 | 57455-83-1 |
| VATYELLOW26 | VATYELLOW26 | |
| Vat Yellow 2 | 2,8-ジフェニルアントラ[2,1-d:6,5-d']ビスチアゾール-6,12-ジオン | 129-09-9 |
| Vat Yellow 12 (C.I.) | N,N'-ビス(5-ベンゾイルアミノ-9,10-ジヒドロ-9,10-ジオキソアントラセン-1-イル)オキサミド | 6370-75-8 |
| Vat Yellow 4 | ジベンゾ[b,def]クリセン-7,14-ジオン | 128-66-5 |
| 2 VAT YELLOW2 | 2 VAT YELLOW2 | |
| Vat Yellow 28 | 5H-ジナフト[2,3-a:2',3'-i]カルバゾール-5,10,15,17(16H)-テトラオン | 4229-15-6 |
| Vat Yellow 3GF | Vat Yellow 3GF | |
| Vat Yellow GCN Paste | Vat Yellow GCN Paste | |
| Vat Yellow 6GD | Vat Yellow 6GD | |
| Vat Yellow FG | Vat Yellow FG | |
| Vat Yellow F3GL | Vat Yellow F3GL | |
| Vat Yellow 4GF | Vat Yellow 4GF | |
| Vat Yellow 46 | Vat Yellow 46 | 12237-50-2 |
| Vat Yellow 7GK | Vat Yellow 7GK | |
| Vav1-D2, Recombinant, Human (VAV Proto-oncogene)
| Vav1-D2, Recombinant, Human (VAV Proto-oncogene)
| |
| Vav1-D1, Recombinant, Human (VAV Proto-oncogene)
| Vav1-D1, Recombinant, Human (VAV Proto-oncogene)
| |
| Vav3-D2, Recombinant, Human (VAV Proto-oncogene)
| Vav3-D2, Recombinant, Human (VAV Proto-oncogene)
| |
| Vav2-D1, Recombinant, Human (VAV Proto-oncogene)
| Vav2-D1, Recombinant, Human (VAV Proto-oncogene)
| |
| Vav2-D2, Recombinant, Human (VAV Proto-oncogene)
| Vav2-D2, Recombinant, Human (VAV Proto-oncogene)
| |
| Vav3-D1, Recombinant, Human (VAV Proto-oncogene)
| Vav3-D1, Recombinant, Human (VAV Proto-oncogene)
| |
| Vav (GDP/GTP Exchange Factor)
| Vav (GDP/GTP Exchange Factor)
| |
| Vav (GDP, GTP Exchange Factor) A
| Vav (GDP, GTP Exchange Factor) A
| |
| Vav2 (GDP, GTP Exchange Factor 2)
| Vav2 (GDP, GTP Exchange Factor 2)
| |
| VAU regimen | VAU regimen | |
| VCAT ANTIBIOTIC SUPPLEMENT | VCATアンチバイオチックサプリメント | |
| VA/VINYL BUTYL BENZOATE/CROTONATES COPOLYMER | （ＶＡ／ｔ－ブチル安息香酸ビニル／クロトン酸）コポリマー | |
| V-CATH protein | V-CATH protein | |
| VBMC | VBMC | |
| VCAV protocol | VCAV protocol | |
| VBMC inter.for 7AVC,Cefixime cefdinir | VBMC inter.for 7AVC,Cefixime cefdinir | |
| Vav1 (phospho Y160)
| Vav1 (phospho Y160)
| |
| Vav3, phosphorylated (Tyr173) (GDP/GTP Exchange Factor)
| Vav3, phosphorylated (Tyr173) (GDP/GTP Exchange Factor)
| |
| Vav1, phosphorylated (Tyr160) (GDP/GTP Exchange Factor)
| Vav1, phosphorylated (Tyr160) (GDP/GTP Exchange Factor)
| |
| VBMF protocol | VBMF protocol | |
| VAV2 protein | VAV2 protein | |
| VAV protocol | VAV protocol | |
| V-c coated | V-c coated | |
| Vb1(Mononitrate&Hcl) | Vb1(Mononitrate&Hcl) | |
| VCCP protocol | VCCP protocol | |
| VBM protocol 2 | VBM protocol 2 | |
| VBM protocol | VBM protocol | |
| VCDP protocol | VCDP protocol | |
| Vax1 protein | Vax1 protein | |
| Vax protein | Vax protein | |
| VCD protocol | VCD protocol | |
| Vax2 protein | Vax2 protein | |
| Vaxstrate | Vaxstrate | |
| VaxSyn HIV-1 (gp160) vaccine | VaxSyn HIV-1 (gp160) vaccine | |
| VAZO 44 | VAZO 44 | |
| VAZO 56 & 68 | VAZO 56 & 68 | |
| VAZO 52 | VAZO 52 | |
| VAZO 50 | VAZO 50 | |
| VAZO 88 | VAZO 88 | |
| VAZO 76 | VAZO 76 | |
| VAZO 64(AIBN) | VAZO 64(AIBN) | |
| VAZO 56 WSP | VAZO 56 WSP | |
| VAZO 44WSP | VAZO 44WSP | |
| VAZO WSP 56 | VAZO WSP 56 | |
| VAZO 56 WSW | VAZO 56 WSW | |
| VAZO 68WSP | VAZO 68WSP | |
| VBP1 protein | VBP1 protein | |
| VCH-916 | VCH-916 | 1200133-34-1 |
| VCH-040 | VCH-040 | 895133-94-5 |
| VCH-759 | VCH-759 | 713139-25-4 |
| VbrA protein | VbrA protein | |
| Vb6(PyridoxineHcl) | Vb6(PyridoxineHcl) | |
| VD 99-11 | VD 99-11 | |
| VD2 | VD2 | |
| VD3 | VD3 | |
| vBRIDP | vBRIDP(regR) | 384842-25-5 |
| v[4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexyl]-carbaMic acid tert-butyl ester | v[4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexyl]-carbaMic acid tert-butyl ester | |
| VCI Gasify antirust antistatic packaging material | VCI Gasify antirust antistatic packaging material | |
| VCH protocol | VCH protocol | |
| Vb12 sulphate | Vb12 sulphate | |
| VDAC1, Control Peptide (Voltage-Dependent Anion Channel 1, Mitochondrial Porin)
| VDAC1, Control Peptide (Voltage-Dependent Anion Channel 1, Mitochondrial Porin)
| |
| VDBCP protocol | VDBCP protocol | |
| VDA-P protocol | VDA-P protocol | |
| VCMA protocol | VCMA protocol | |
| VBVP protocol | VBVP protocol | |
| VD3-D6 | VD3-D6 | 118584-54-6 |
| VD3 crystall,Cholecalciferol | VD3 crystall,Cholecalciferol | |
| VDE endonuclease | VDE endonuclease | |